Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g)

Brain Research

Volumn 853, Issue 2, 2000, Pages 310-316

  Sogawa, Chiharu Aoki ^a   Miyazaki, Ikuko ^a   Sogawa, Norio ^a   Asanuma, Masato ^a   Ogawa, Norio ^a   Furuta, Hiroaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Antioxidant; Dopamine; Dopamine receptor; Glial cell; Growth inhibitory factor (GIF); Metallothionein III

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BROMOCRIPTINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTATHIONE; GROWTH INHIBITOR; MESSENGER RNA; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE; SULPIRIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GLIA CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC AGENTS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CELL LINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+); GLYCEROLPHOSPHATE DEHYDROGENASE; LEVODOPA; METALLOTHIONEIN; MICE; NEUROGLIA; NOREPINEPHRINE; OXIDOPAMINE; PROTEIN ISOFORMS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITAMIN E;

EID: 0033987764     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02284-2     Document Type: Article

References (29)

1. Amoureux M.-C., Wurch T., Pauwels P.J. Modulation of metallothionein-III mRNA and growth rate of rat C6-glial cells by transfection with human 5-HT1D receptor genes. Biochem. Biophys. Res. Commun. 214:1995;636-645.
2. Anezaki T., Ishiguro H., Hozumi I., Inuzuka T., Hiraiwa M., Kobayashi H., Yuguchi T., Wanaka A., Uda Y., Miyatake T., Yamada K., Tohyama M., Tsuji S. Expression of growth inhibitory factor (GIF) in normal and injured rat brains. Neurochem. Int. 27:1995;89-94.
3. Aoki C., Nakanishi, Sogawa N., Ishii K., Ogawa N., Takigawa M., Furuta H. Stimulatory effects of 4-methylcatechol, dopamine and levodopa on the expression of metallothionein-III (GIF) mRNA in immortalized mouse brain glial cells (VR-2g). Brain Res. 792:1998;335-339.
4. Aschner M. The functional significance of brain metallothioneins. FASEB J. 10:1996;1129-1136.
5. Aschner M., Cherian M.G., Klassen C.D., Palmiter R.D., Erickson J.C., Bush A.I. Metallothionein in brain. The role in physiology and pathology. Toxicol. Appl. Pharmacol. 142:1997;229-242.
6. Aschner M. Metallothionein (MT) isoforms in the central nervous system (CNS): regional and cell-specific distribution and potential functions as an antioxidant. Neurotoxicology. 19:1998;653-660.
7. Cadenas E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 58:1989;79-110.
8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
9. Choudhuri S., Kramer K.K., Berman N.E., Dalton T.P., Andrews G.K., Klaassen C.D. Constitutive expression of metallothionein genes in mouse brain. Toxicol. Appl. Pharmacol. 131:1995;144-154.
10. Cohen G., Heikkila R.E. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J. Biol. Chem. 249:1974;2447-2452.
11. Erickson J.C., Sewell A.K., Jensen L.T., Winge D.R., Palmiter R.D. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res. 649:1994;297-304.
12. Furukawa Y., Furukawa S., Ikeda F., Satoyoshi E., Hayashi K. Aliphatic side chain of catecholamine potentiates the stimulatory effect of the catechol part on the synthesis of nerve growth factor. FEBS Lett. 208:1986;258-262.
13. Furukawa Y., Tomioka N., Sato W., Satoyoshi E., Hayashi K., Furukawa S. Catecholamines increase nerve growth factor mRNA content in both mouse astroglial cells and fibroblast cells. FEBS Lett. 247:1989;463-467.
14. Furukawa Y., Fukazawa N., Miyama Y., Hayashi K., Frukawa S. Stimulatory effect of 4-alkylcatechols and their diacetylated derivatives on the synthesis of nerve growth factor. Biochem. Pharmacol. 40:1990;2337-2342.
15. Hozumi I., Inuzuka T., Hiraiwa M., Ichida Y., Anezaki T., Ishiguro H., Kobayashi H., Uda Y., Tadashi M., Tsuji S. Changes of growth inhibitory factor after stab wounds in rat brain. Brain Res. 688:1995;143-148.
16. Hozumi I., Inuzuka T., Tsuji S. Brain injury and growth inhibitory factor (GIF) - a mini review. Neurochem. Res. 23:1998;319-328.
17. Ishii K., Inoue H., Hakura A., Araki W., Masuda T. Immortalization of fetal mouse brain glial cells by human papillomavirus type 16 E7 genes. Cell Struct. Funct. 17:1992;197-202.
18. Kramer K.K., Lie J., Choudhuri S., Klassen C.D. Induction of metallothionein mRNA and protein in murine astrocyte cultures. Toxicol. Appl. Pharmacol. 136:1996;94-100.
19. Kramer K.K., Zoelle J.T., Klassen C.D. Induction of metallothionein mRNA and protein in primary murine neuron cultures. Toxicol. Appl. Pharmacol. 141:1996;1-7.
20. Masters B.A., Quaife C.J., Erickson J.C., Kelly E.J., Froelick G.J., Zambrowicz B.P., Brister R.L., Palmiter R.D. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles. J. Neurosci. 14:1994;5844-5857.
21. Nakanishi T., Ishii K., Katayama M., Araki W., Iwata E., Ogawa N. Characterization of neurotrophic factor produced by immortalized mouse brain glial cells (VR-2g). Biochem. Mol. Biol. Int. 36:1995;991-999.
22. Palmiter R.D., Findley S.D., Whitmore T.E., Durnam D.M. MT-III, a brain-specific member of the metallothionein gene family. Proc. Natl. Acad. Sci. U.S.A. 89:1992;6333-6337.
23. Perry T.L., Godin D.V., Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
24. Sachs C.H., Jonsson G. Mechanism of action of 6-hydroxydopamine. Biochem. Pharmac. 24:1975;1-8.
25. Uchida Y., Takio K., Titani K., Ihara Y., Tomonaga M. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron. 7:1991;337-347.
26. Uchida Y. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases. Biol. Signals. 3:1994;211-215.
27. Uchida Y., Masumizu A., Ihara Y. Protection of cultured cortical neurons from β-amyloid neurotoxicity. Nuerochem. Res. 21:1995;320-321.
28. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by L-dopa. J. Clin. Invest. 95:1995;2458-2464.
29. Zheng H., Berman N.E.J., Klassen C.D. Chemical modulation of metallothionein I and III mRNA in mouse brain. Neurochem. Int. 27:1995;43-58.